Truist raised the firm’s price target on Molina Healthcare to $460 from $435 and keeps a Buy rating on the shares. The firm is adjusting its model to reflect the company’s Q4 earnings beat and FY24 guidance, also raising its FY25 EPS view to $27.00 from $26.72, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOH:
- Snowflake downgraded, Coinbase upgraded: Wall Street’s top analyst calls
- Wells upgrades Molina to Equal Weight on Medicaid opportunities
- Molina Healthcare upgraded to Equal Weight from Underweight at Wells Fargo
- Molina Healthcare Inc’s New Economy & Political Environment Risk – A Cause for Worry?
- Molina Healthcare price target lowered to $357 from $375 at Deutsche Bank